What can be concluded from the Oxcheck and British family heart studies: Commentary on cost effectiveness analyses

British Medical Journal

Volumn 312, Issue 7041, 1996, Pages 1274-1278

  Wonderling, David ^a   Langham, Susan ^b   Buxton, Martin ^a,c   Normand, Charles ^b,c   McDermott, Christine ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Department of Health Economics ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CORONARY RISK; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; GENERAL PRACTICE; HEALTH CARE COST; HUMAN; LIFESTYLE; MALE; MODEL; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

EID: 0029869879     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7041.1274     Document Type: Article

References (25)

1. Imperial Cancer Research Fund OXCHECK study group. Effectiveness of health checks conducted by nurses in primary care: results of the Oxcheck study after one year. BMJ 1994; 308:308-12.
2. Imperial Cancer Research Fund Oxcheck study. Effectiveness of health checks conducted by nurses in primary care: final results of the Oxcheck study. BMJ 1995;310:1099-104.
3. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994;308:313-20.
4. Stott N. Screening for cardiovascular risk in general practice: blanket health promotion is a waste of resources [editorial]. BMJ 1994;308:285-6.
5. Field K, Thorogood M, Silagy C, Normand C, O'Neill C, Muir J. Strategies for reducing coronary risk factors in primary care: which is most cost effective? BMJ 1995;310:1109-12.
6. Langham S, Thorogood M, Normand C, Muir J, Jones L, Fowler G. Costs and cost-effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ 1996;312:1265-8.
7. Wonderling D, McDermott C, Buxton M, Kinmonth A-L, Pyke S, Thompson S, Wood D. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ 1996;312:1269-73.
8. Tunstall-Pedoe H. The Dundee coronary risk disk for management of change in risk factors. BMJ 1991;303:744-7.
9. Office of Population Censuses and Surveys. Mortality statistics: cause. England and Wales 1991. London: HMSO, 1991. (Series DH2.)
10. Department of Health. Assessing the options: CHD/stroke (Target-effectiveness and cost-effectiveness of interventions to reduce CHD and stroke mortality). London: Department of Health, 1994:appendix 6.
11. Parsonage P, Neuberger H. Discounting and health benefits. Health Economics 1992;1:71-9.
12. Department of Health. Policy appraisal and health London: Department of Health, 1995.
13. Mason J, Drummond M, Torrance G. Some guidelines on the use of cost effectiveness league tables. BMJ 1993;306:570-2.
14. Maynard A. Developing the health care market. Economic Journal 1991;101:1277-86.
15. Drummond MF, Heyse J, Cook J, McGuire A. Selection of end points in economic evaluations of coronary-heart-disease interventions. Medical Decision Making 1993;13:184-90.
16. Department of Health, Economics and Operational Research Division. Register of cost-effectiveness studies. London: Department of Health, 1994.
17. Office of Health Economics-IFPMA. Health economic evaluations database [computer software] London: OHE-IFPMA, 1995.
18. Organisation for Economic Cooperation and Development-Centre de Recherche, d'Etude et de Documentation en Economie de la Santé. OECD health data/Eco-sante OCDE: A software package for the cross-national comparisons of health systems [computer software]. Paris: OECD-CREDES, 1995.
19. Kristiansen IS, Eggen AE, Thelle DS. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while? BMJ 1991;302:1119-22.
20. Reckless JPD. Cost-effectiveness of clinical care for hyperlipidaemia. In: Lewis B, Assman G. Social and economic contexts of coronary prevention. London: Current Medical Literature, 1990:94-111.
21. Akehurst RL, Piercy J. Cost-effectiveness of the use of transdermal Nicorette patches relative to GP counselling and nicotine gum in the prevention of smoking-related disease. British Journal of Medical Economics 1994;7:115-22.
22. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counselling smokers to quit. JAMA 1989;261:75-9.
23. Nissinen A, Tuomilehto J, Kottke TE, Puska P. Cost-effectiveness of the North Karelia hypertension program. Medical Care 1986;24:767-80.
24. Assman G, Schulte H. Primary prevention of coronary heart disease in the Federal Republic of Germany: a cost-effectiveness analysis. In Lewis B, Assman G. Social and economic contexts of coronary prevention. London: Current Medical Literature, 1990:37-56.
25. Weinstein MC, Stason WB. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health 1985;6:41-63.